Serum and peritoneal fluid levels of IGF I and II and insulinlike growth binding protein-3 in endometriosis
Observational
OA: closed
CC0
⤵ 29 in-corpus citations
AI-generated summary
This study found that serum and peritoneal fluid levels of IGF I, IGF II, and IGFBP 3 differ between endometriosis patients and controls, with higher serum IGF I correlating with late-stage endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To examine whether insulinlike growth factor I (IGF I), IGF II and IGF binding protein 3 (IGFBP 3) in serum and peritoneal fluid (PF) correlate with the presence and severity of endometriosis.
STUDY DESIGN: Case-control study including 29 patients with endometriosis and 15 controls. The revised American Fertility Society classification stages of I and II were pooled as early-stage (n = 15), and stages III and IV were taken as late stage (n = 14). Simultaneous sampling of blood and PF was performed during laparoscopy, and IGF I, IGF II and IGFBP 3 levels were determined by immunoradiometric assay.
RESULTS: The serum levels of all three proteins were higher than PF levels except for a reversed IGF I PF: serum ratio in the early stage. There were no significant differences in IGF II and IGFBP 3 levels among the groups. The mean serum IGF I levels of controls and early-stage patients were significantly lower than those in the late stage. Also, mean PF IGF I levels in controls were significantly lower than in the late stage.
CONCLUSION: IGF I may be an important mediator in the development and/or maintenance of endometriosis or progression to late-stage disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (29)
- Differential Expression of Insulin Growth Factor 1 (IGF-1) Isoforms in Different Types of Endometriosis: Preliminary Results of a Single-Center Study 2023
- MiR-19b-3p inhibits cell viability and proliferation and promotes apoptosis by targeting IGF1 in KGN cells 2023
- Endometriosis Research: From Bench to Bedside 2022
- Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls 2021
- Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives 2020
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies 2018
- Associations among body size across the life course, adult height and endometriosis 2017
- Epidemiological and Clinical Risk Factors for Endometriosis 2017
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis 2015
- Current Insights and Future Advances in Endometriosis Diagnostics 2012
- The emerging role of epigenetics in the aetiology of endometriosis. 2011
- Peripheral biomarkers of endometriosis: a systematic review 2010
- Deregulation of LOXL1 and HTRA1 gene expression in endometriosis 2010
- A prospective study of body size during childhood and early adulthood and the incidence of endometriosis 2010
- Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis 2008
- Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? 2006
- Endometriosis: harmful survival of an ectopic tissue 2006
- Serum and endometrial markers 2004
- Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients 2004
- In utero exposures and the incidence of endometriosis 2004
- Concentrations of alpha-fetoprotein, insulin-like growth factor binding protein-3, c-erbB-2, and epidermal growth factor in serum of patients with endometriosis 2004
- Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis 2003
- Spatially heterogeneous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissues 2002
- Spatially Heterogenous Expression of Aromatase P450 through Promoter II Is Closely Correlated with the Level of Steroidogenic Factor-1 Transcript in Endometrioma Tissues 2002
- Angiogenic factors in endometriosis 2002
- IGF-1 in gynaecology and obstetrics: update 2002 2002
- Angiogenesis in Endometriosis 2001
- Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis 2000
Source provenance
- europepmc
- last seen: 2026-10-17T06:09:56.316927+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T20:58:57.924351+00:00
License: CC0
· commercial use OK